Reverba Global powers scientific patient and HCP engagement with scalable, compliant technology—delivering real-time insights and resources from discovery through commercialization.
Reverba Global
Advertisement
Articles by Reverba Global
In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.
In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.
Sponsored Content
The biopharma industry launched COVID vaccines and treatments in record time. How did this impact consumer trust? We asked, and compared survey results with 2017 data.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
2
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
3
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
4
The Industry's Interest in Vaccine Platforms
5